Melissa E Munroe is a prominent inventor based in Oklahoma City, OK (US). She has made significant contributions to the field of medical research, particularly in the area of systemic lupus erythematosus (SLE). With a total of 3 patents to her name, her work focuses on identifying biomarkers that can improve the diagnosis and treatment of this complex autoimmune disease.

Latest Patents

One of her latest patents is titled "Biomarkers for assessing risk of transitioning to systemic lupus erythematosus classification and disease pathogenesis." This invention includes methods, systems, and kits for identifying and modifying the treatment of SLE patients before the presence of autoantibodies. The process involves obtaining a dataset representing protein expression level values for cytokines and molecules, assessing these levels for both innate and adaptive serum mediators, and determining the likelihood of a patient developing SLE compared to a control group.

Another significant patent is "Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare." This invention focuses on identifying biomarkers that predict impending SLE disease flares, along with methods for treating patients identified through these biomarkers.

Career Highlights

Melissa E Munroe is affiliated with the Oklahoma Medical Research Foundation, where she conducts her research. Her work has been instrumental in advancing the understanding of SLE and improving patient outcomes through innovative diagnostic methods.

Collaborations

One of her notable collaborators is Judith Ann James, who also contributes to the research efforts in the field of lupus.

Conclusion

Melissa E Munroe's innovative work in lupus research has the potential to transform the way this autoimmune disease is diagnosed and treated. Her contributions through her patents reflect her commitment to improving patient care and advancing medical science.

This text is generated by artificial intelligence and may not be accurate.